Sonnet BioTherapeutics Holdings, Inc. (SONN) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Sonnet BioTherapeutics Holdings, Inc. (SONN) Bundle
Enhance your investment strategies with the Sonnet BioTherapeutics Holdings, Inc. (SONN) DCF Calculator! Dive into real financial data, adjust growth projections and expenses, and observe how these alterations affect the intrinsic value of Sonnet BioTherapeutics instantly.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .5 | .3 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | -27.64 | -57.76 | -87.4 | -43.2 | -43.2 | -43.2 | -43.2 | -43.2 |
| EBITDA | -24.2 | -25.0 | -29.6 | -18.7 | -11.8 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | -5167.69 | -8451.69 | -12663.22 | -63617.91 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .1 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 19.68 | 26.65 | 51.25 | 0 | 39.52 | 39.52 | 39.52 | 39.52 | 39.52 |
| EBIT | -24.3 | -25.1 | -29.7 | -18.8 | -11.8 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | -5187.36 | -8478.34 | -12714.47 | -63617.91 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 7.3 | 27.6 | 3.1 | 2.3 | .1 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .8 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 0 | 0 | 532.17 | 0 | 40 | 40 | 40 | 40 | 40 |
| Inventories | .0 | .0 | -.7 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 0 | -204.98 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 2.1 | 3.8 | 4.8 | 2.2 | 2.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 781.86 | 1358.03 | 1489.8 | 11722.41 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.1 | .0 | -.9 | -.4 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | -0.74913 | -256.18 | -299.89 | 0 | -40.15 | -40.15 | -40.15 | -40.15 | -40.15 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -31.1 | -25.1 | -29.7 | -18.8 | -11.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -29.1 | -23.3 | -28.8 | -23.2 | -11.1 | -2.2 | .0 | .0 | .0 | .0 |
| WACC, % | 8.81 | 8.81 | 8.81 | 8.81 | 8.81 | 8.81 | 8.81 | 8.81 | 8.81 | 8.81 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -2 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | -3.07 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Sonnet BioTherapeutics Holdings, Inc. (SONN) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive Biotech Data: Gain access to accurate pre-loaded historical data and future projections specific to Sonnet BioTherapeutics Holdings, Inc. (SONN).
- Tailored Forecast Assumptions: Modify highlighted cells for key metrics like WACC, growth rates, and profit margins.
- Real-Time Calculations: Instant updates to DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Clear and concise charts and summaries to help visualize your valuation outcomes.
- Suitable for All Levels: An accessible, intuitive format designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Sonnet BioTherapeutics data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Sonnet BioTherapeutics' intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for Sonnet BioTherapeutics Holdings, Inc. (SONN)?
- Accurate Data: Utilize real Sonnet BioTherapeutics financials for dependable valuation assessments.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and comprehensive instructions make it accessible for all users.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment of Sonnet BioTherapeutics Holdings, Inc. (SONN).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations.
- Consultants and Advisors: Deliver precise valuation insights to clients interested in Sonnet BioTherapeutics Holdings, Inc. (SONN).
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
- Biotech Enthusiasts: Gain insights into how biotech firms like Sonnet BioTherapeutics Holdings, Inc. (SONN) are valued in the financial markets.
What the Sonnet BioTherapeutics Template Contains
- Comprehensive DCF Model: Editable template featuring in-depth valuation calculations tailored for Sonnet BioTherapeutics.
- Real-World Data: Sonnet BioTherapeutics Holdings, Inc. (SONN) historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis of profitability, efficiency, and leverage specific to Sonnet BioTherapeutics.
- Dashboard with Visual Outputs: Engaging charts and tables that present clear, actionable results for decision-making.